news Dupixent rolled on with another phase 3 win in prurigo nodularis – FiercePharma alex mun September 27, 2022 1 min read Dupixent rolled on with another phase 3 win in prurigo nodularis FiercePharmasource Chat read-only to anonymous users. Chat with Anyone and Anywhere. Only registered users are allowed to send messages. Loading the chat ... 20085 Register Login Continue Reading Previous: JP Morgan teams up with Cleareye.ai for digitising trade finance solution – FinextraNext: Deep sea fishing company fined and boat confiscated; skipper fined for illegal fishing – New Zealand Herald Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ